
geicogroup.com
Feb 25, 2025, 13:28
Exploratory analysis of biomarkers and histology in DUO-E pMMR – Spanish Gynaecological Cancer Research Group
GEICO – Spanish Gynaecological Cancer Research Group shared a post on LinkedIn:
“Exploratory analysis of biomarkers and histology in DUO-E pMMR.
The authors conclude that the pMMR subpopulation is highly heterogeneous, with frequent overlap of histologies and biomarkers. 84% of patients were positive for at least one biomarker.
Additionally, the incorporation of olaparib maintenance improved progression-free survival (PFS) across different histological subgroups and biomarkers.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 25, 2025, 11:33
Feb 25, 2025, 11:24
Feb 25, 2025, 11:23
Feb 25, 2025, 11:17
Feb 25, 2025, 11:15
Feb 25, 2025, 11:11